Skip to main content
OpenTrials

Clinical trial condition

Hyperuricemia

Explore clinical trials studying Hyperuricemia. Study availability and eligibility vary by location and protocol.

113 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Hyperuricemia trial results

Completed

Open Label PK, PD and DDI of Dotinurad and Allopurinol in Gout Patients With Hyperuricemia

NCT06056570

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +12 more
Locations
  • Clinical Research of West Florida Clearwater, Florida, United States
  • Panax Clinical Research Miami Lakes, Florida, United States
  • Southwest Rheumatology Research Mesquite, Texas, United States
  • Endeavor Clinical Trials San Antonio, Texas, United States
View Trial Details
Completed

Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302)

NCT06439602

Conditions
Arthritis, Arthritis, Gouty, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +14 more
Locations
  • Arthrosi Investigative Site (106) Foley, Alabama, United States
  • Arthrosi Investigative Site (139) Anchorage, Alaska, United States
  • Arthrosi Investigative Site (160) Peoria, Arizona, United States
  • Arthrosi Investigative Site (112) Phoenix, Arizona, United States
View all 68 locations
View Trial Details
Completed

A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia

NCT03934099

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +12 more
Locations
  • Synexus Clinical Research Birmingham, Alabama, United States
  • Synexus Clinical Research Chandler, Arizona, United States
  • Synexus Clinical Research Mesa, Arizona, United States
  • Synexus Clinical Research Tucson, Arizona, United States
View all 34 locations
View Trial Details
Completed

Tigulixostat, Phase 3 Study, Placebo Controlled in Gout Patients

NCT05586958

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Medvin Clinical Research Covina, California, United States
  • Clinical Research of West Florida, Inc. Clearwater, Florida, United States
  • Herco Medical and Research Center, Inc Coral Gables, Florida, United States
View all 52 locations
View Trial Details
Completed

Tigulixostat, Phase 3 Study, Allopurinol Controlled in Gout Patients

NCT05586971

Conditions
Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Crystal Arthropathies, +14 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Alliance for Multispecialty Research, LLC Daphne, Alabama, United States
  • Alliance for Multispecialty Research, LLC Mobile, Alabama, United States
  • Syed Research Consultants, LLC Muscle Shoals, Alabama, United States
View all 279 locations
View Trial Details

Related conditions